Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (24 ops.)
Latest filing published 05 Oct 2026 for Castle Biosciences INC, €12k. Read the official filing
Filing timeline
BuySaleKristen M. Oelschlager
Insider track record
Disclosed buys
0
Disclosed sells
24
Signal history
Kristen M. Oelschlager: trading record in brief
This profile gathers the share dealings of Kristen M. Oelschlager in Castle Biosciences Inc, where the filings describe the role as senior executive. Over a trading history stretching from 27 September 2021 to 1 October 2026, the count stands at 39 filings.
On the market, this insider has only sold: 24 sales, €4.6M in total. No amount is published for 1 filing, which the totals therefore leave out. Other entries cover 4 share grants and 11 option exercises. In 2026 alone, the filings show no purchases and 13 sales.
Most recently, on 5 October 2026, the filings show an option exercise worth €12k in Castle Biosciences Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Kristen M. Oelschlager
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations39 total
4,153 shares@ US$3.380.0013% mcap0.3% of flowCommon StockSEC:0001628280-26-064912:0
2,807 shares@ US$35.750.0091% mcap2.0% of flowCommon StockSEC:0001628280-26-064912:1
1,346 shares@ US$36.380.0044% mcap1.0% of flowCommon StockSEC:0001628280-26-064912:2
4,152 shares@ US$3.380.0013% mcap0.3% of flowCommon StockSEC:0001628280-26-060430:0
3,952 shares@ US$33.360.012% mcap2.7% of flowCommon StockSEC:0001628280-26-060430:1
200 shares@ US$34.020.0006% mcap0.1% of flowCommon StockSEC:0001628280-26-060430:2
12,218 shares@ US$33.6870.037% mcap8.4% of flowCommon StockSEC:0001628280-26-059091:0
7,161 shares@ US$34.2630.022% mcap5.0% of flowCommon StockSEC:0001628280-26-059091:1
5,223 shares@ US$34.6390.016% mcap3.7% of flowCommon StockSEC:0001628280-26-059091:2
3,000 shares@ US$29.120.0079% mcap1.8% of flowCommon StockSEC:0001628280-26-053391:0
4,486 shares@ US$30.000.012% mcap2.8% of flowCommon StockSEC:0001628280-26-053391:1
1,100 shares@ US$30.620.0030% mcap0.7% of flowCommon StockSEC:0001628280-26-053391:2
8,186 shares@ US$24.400.018% mcap4.2% of flowCommon StockSEC:0001628280-26-047286:0
400 shares@ US$24.780.0009% mcap0.2% of flowCommon StockSEC:0001628280-26-047286:1
8,587 sharesCommon StockSEC:0001628280-26-044327:0
2,427 shares@ US$27.571.4% of flowCommon StockSEC:0001628280-26-015352:0
9,207 shares0Common StockSEC:0001856565-26-000002:0
14,888 shares@ US$39.31311.9% of flowCommon StockSEC:0001628280-25-058246:0
15,961 sharesCommon StockSEC:0001628280-25-056629:0
18,932 shares@ US$35.1013.7% of flowCommon StockSEC:0001628280-25-052013:0
18,007 shares@ US$21.6914.4% of flowCommon StockSEC:0001628280-25-049176:0
12,678 shares@ US$25.046.5% of flowCommon StockSEC:0001628280-25-049189:0
12,677 shares@ US$22.0195.7% of flowCommon StockSEC:0001856565-25-000007:0
18,007 shares@ US$21.698.0% of flowCommon StockSEC:0001856565-25-000006:0
10,640 shares0Common StockSEC:0001856565-25-000003:0
25 of 39 declarations
